Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2016

01-02-2016 | Colorectal Cancer

Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer

Authors: Michael A. Choti, MD, MBA, Michele Thomas, MS, MBA, Schiffon L. Wong, MPH, Michael Eaddy, PharmD, PhD, Timothy M. Pawlik, MD, MPH, PhD, Kenzo Hirose, MD, Matthew J. Weiss, MD, Jonathan Kish, PhD, MPH, Mark R. Green, MD

Published in: Annals of Surgical Oncology | Issue 2/2016

Login to get access

Abstract

Background

Liver resection is a key therapeutic strategy to improve survival in patients with colorectal cancer liver metastases. Underutilization may negatively affect outcomes. Using a Web-based survey and standardized imaging scenarios, this study assessed medical oncologists’ (MOs) perceptions of resectability, preferences for chemotherapy sequencing, and referral for surgical consultation in a static patient profile of good performance status and no extrahepatic spread but varying bulk and distribution of disease.

Methods

A total of 190 US-based MOs were surveyed. A single patient profile was created and combined with 10 different sets of liver computed tomographic images displaying a broad spectrum of metastases. Assessments of resectability and ranking were compared with the results obtained from an expert panel of 3 hepatic surgeons.

Results

The expert hepatic surgeons designated 8 scans resectable, 1 borderline resectable/convertible, and 1 unresectable. In the 8 resectable cases, 34.4 % of MOS perceived the case to be initially resectable, 41.7 % potentially resectable after chemotherapy response, and 23.9 % unresectable. Increasing number of lesions, larger tumor diameter, and bilateral disease were associated with lower resectability perception (P < 0.01). Among those cases considered resectable by MOs, they preferred initial resection (54.2 %) over neoadjuvant chemotherapy (38.4 %). Initial referral for surgical consultation was generally favored only for cases considered initially resectable by MOs.

Conclusions

This study confirms both potential discrepancies between MOs’ and hepatic surgeons’ perception of resectability and underutilization of early surgical consultation for patients with potentially resectable colorectal cancer liver metastases and underscores the importance of an evaluation that includes an experienced hepatic surgeon.
Literature
1.
go back to reference de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RG, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg. 2009;250:440–8.PubMed de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RG, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg. 2009;250:440–8.PubMed
2.
go back to reference Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575–80.PubMedCrossRef Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575–80.PubMedCrossRef
3.
go back to reference Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509–22.PubMedPubMedCentralCrossRef Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509–22.PubMedPubMedCentralCrossRef
4.
go back to reference Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000;231:487–99.PubMedPubMedCentralCrossRef Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000;231:487–99.PubMedPubMedCentralCrossRef
5.
go back to reference Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225–39.PubMedPubMedCentralCrossRef Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225–39.PubMedPubMedCentralCrossRef
6.
go back to reference National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Colon cancer. Version 2.2015. 2014. p. 1–143. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Colon cancer. Version 2.2015. 2014. p. 1–143.
7.
go back to reference Nathan H, Bridges JF, Cosgrove DP, Diaz LA Jr, Laheru DA, Herman,JM, et al. Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making. Ann Surg Oncol. 2012;19:3668–76.PubMedPubMedCentralCrossRef Nathan H, Bridges JF, Cosgrove DP, Diaz LA Jr, Laheru DA, Herman,JM, et al. Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making. Ann Surg Oncol. 2012;19:3668–76.PubMedPubMedCentralCrossRef
9.
go back to reference House MG, Ito H, Gonen M, Fong Y, Allen PJ, DeMatteo RP, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210:744–55.PubMedCrossRef House MG, Ito H, Gonen M, Fong Y, Allen PJ, DeMatteo RP, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210:744–55.PubMedCrossRef
10.
go back to reference Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–24.PubMedPubMedCentralCrossRef Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–24.PubMedPubMedCentralCrossRef
11.
go back to reference de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P, et al. Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg. 2011;253:1069–79.PubMedCrossRef de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P, et al. Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg. 2011;253:1069–79.PubMedCrossRef
12.
go back to reference Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg. 2012;255:237–47.PubMedCrossRef Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA. Chemotherapy before liver resection of colorectal metastases: friend or foe? Ann Surg. 2012;255:237–47.PubMedCrossRef
13.
go back to reference Mayo SC, Heckman JE, Shore AD, Nathan H, Parikh AA, Bridges JF, et al. Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery. 2011;150:204–16.PubMedPubMedCentralCrossRef Mayo SC, Heckman JE, Shore AD, Nathan H, Parikh AA, Bridges JF, et al. Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis. Surgery. 2011;150:204–16.PubMedPubMedCentralCrossRef
14.
go back to reference Nanji S, Cleary S, Ryan P, Guindi M, Selvarajah S, Grieg P, et al. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol. 2013;20:295–304.PubMedCrossRef Nanji S, Cleary S, Ryan P, Guindi M, Selvarajah S, Grieg P, et al. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Ann Surg Oncol. 2013;20:295–304.PubMedCrossRef
15.
go back to reference Nordlinger B, Vauthey JN, Poston G, Benoist S, Rougier P, Van Cutsem E. The timing of chemotherapy and surgery for the treatment of colorectal liver metastases. Clin Colorectal Cancer. 2010;9:212–8.PubMedCrossRef Nordlinger B, Vauthey JN, Poston G, Benoist S, Rougier P, Van Cutsem E. The timing of chemotherapy and surgery for the treatment of colorectal liver metastases. Clin Colorectal Cancer. 2010;9:212–8.PubMedCrossRef
16.
go back to reference Ksienski D, Woods R, Speers C, Kennecke H. Patterns of referral and resection among patients with liver-only metastatic colorectal cancer (MCRC). Ann Surg Oncol. 2010;17:3085–93.PubMedCrossRef Ksienski D, Woods R, Speers C, Kennecke H. Patterns of referral and resection among patients with liver-only metastatic colorectal cancer (MCRC). Ann Surg Oncol. 2010;17:3085–93.PubMedCrossRef
17.
go back to reference Wei AC, Sandhu L, Devitt KS, Gagliardi AR, Kennedy ED, Urbach DR, et al. Practice patterns for the management of hepatic metastases from colorectal cancer: a mixed methods analysis. Ann Surg Oncol. 2013;20:1567–74.PubMedCrossRef Wei AC, Sandhu L, Devitt KS, Gagliardi AR, Kennedy ED, Urbach DR, et al. Practice patterns for the management of hepatic metastases from colorectal cancer: a mixed methods analysis. Ann Surg Oncol. 2013;20:1567–74.PubMedCrossRef
Metadata
Title
Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer
Authors
Michael A. Choti, MD, MBA
Michele Thomas, MS, MBA
Schiffon L. Wong, MPH
Michael Eaddy, PharmD, PhD
Timothy M. Pawlik, MD, MPH, PhD
Kenzo Hirose, MD
Matthew J. Weiss, MD
Jonathan Kish, PhD, MPH
Mark R. Green, MD
Publication date
01-02-2016
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 2/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4925-1

Other articles of this Issue 2/2016

Annals of Surgical Oncology 2/2016 Go to the issue